
Raymond Ltd’s board has approved a name change to Raymond Aerospace, Defence & Engineering Ltd. KEC International has secured turnkey orders worth Rs 2,872 crore from Power Grid Corporation of India for transmission lines. Ramky Infrastructure has signed a Rs 588.57-crore contract with Rail Vikas Nigam for residential towers in Chhattisgarh.

B.L. Kashyap and Sons has won a Rs 495.86-crore order from Signature Global for civil and MEP works. Honasa Consumer has elevated Vipul Maheshwari to Chief Product & Technology Officer. The USFDA issued four Form 483 observations to Gland Pharma at its Dundigal facility and one observation to Lupin’s Goa plant. Orchid Pharma has signed a licensing and supply agreement for Exblifep in nine Latin American markets. Transworld Shipping Lines has agreed to acquire two container vessels for a combined $42.78 million.
The Hindustan Business Line’s stock-news round-up lists 15 companies and gives detailed order values, inspection dates, and contract terms for each. News9live’s list is shorter, names 13 stocks for Q2 results, and includes quarterly earnings figures for Infosys, Kotak Mahindra Bank, and IndusInd Bank that are absent from the first source. The two outlets are neutral-report stock-news lists, neither editorialises on the disclosures. Coverage is uniform straight reporting of company announcements, with each outlet selecting a different set of stocks. The most concrete open point is the USFDA’s Form 483 observations to Lupin and Gland Pharma, which both companies have said they will address within the stipulated timeframe.
Coverage: 2 sources, 2 neutral
Sources (2): thehindubusinessline.com (neutral report), news9live.com (neutral report)
This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Methodology and corrections.